Report Detail
Global Chronic Kidney Disease (CKD) Drugs Market Research Report 2019
- RnM3041820 |
- 28 February, 2019 |
- Global |
- 97 Pages |
- QYResearch |
- Pharma & Healthcare
Chronic Kidney Disease (CKD) Drugs are drugs for Chronic kidney disease, which also called chronic kidney failure, describes the gradual loss of kidney function.
Calcium channel blockers surfaced as the key drug class
The hospitals segment, which is the current market leader, is expected to continue its dominance in this market over the next few years.
The global Chronic Kidney Disease (CKD) Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Chronic Kidney Disease (CKD) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chronic Kidney Disease (CKD) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Pfizer, Inc.
Amgen
Roche
GlaxoSmithKline (GSK)
Allergan
AbbVie
Kissei Pharmaceutical Co., Ltd.
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
ACE inhibitors
Angiotensin-II receptor blockers
Calcium channel blockers
Beta blockers: BREVIBLOC, Bystolic
Others
Segment by Application
Hospitals
Specialty Clinics
Table of Contents
Executive Summary
1 Chronic Kidney Disease (CKD) Drugs Market Overview
- 1.1 Product Overview and Scope of Chronic Kidney Disease (CKD) Drugs
- 1.2 Chronic Kidney Disease (CKD) Drugs Segment by Type
- 1.2.1 Global Chronic Kidney Disease (CKD) Drugs Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 ACE inhibitors
- 1.2.3 Angiotensin-II receptor blockers
- 1.2.4 Calcium channel blockers
- 1.2.5 Beta blockers: BREVIBLOC, Bystolic
- 1.2.6 Others
- 1.3 Chronic Kidney Disease (CKD) Drugs Segment by Application
- 1.3.1 Chronic Kidney Disease (CKD) Drugs Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospitals
- 1.3.3 Specialty Clinics
- 1.4 Global Chronic Kidney Disease (CKD) Drugs Market by Region
- 1.4.1 Global Chronic Kidney Disease (CKD) Drugs Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Chronic Kidney Disease (CKD) Drugs Market Size
- 1.5.1 Global Chronic Kidney Disease (CKD) Drugs Revenue (2014-2025)
- 1.5.2 Global Chronic Kidney Disease (CKD) Drugs Production (2014-2025)
2 Global Chronic Kidney Disease (CKD) Drugs Market Competition by Manufacturers
- 2.1 Global Chronic Kidney Disease (CKD) Drugs Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Chronic Kidney Disease (CKD) Drugs Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Chronic Kidney Disease (CKD) Drugs Production Sites, Area Served, Product Types
- 2.5 Chronic Kidney Disease (CKD) Drugs Market Competitive Situation and Trends
- 2.5.1 Chronic Kidney Disease (CKD) Drugs Market Concentration Rate
- 2.5.2 Chronic Kidney Disease (CKD) Drugs Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Chronic Kidney Disease (CKD) Drugs Production Market Share by Regions
- 3.1 Global Chronic Kidney Disease (CKD) Drugs Production Market Share by Regions
- 3.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Regions (2014-2019)
- 3.3 Global Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Chronic Kidney Disease (CKD) Drugs Production
- 3.4.1 North America Chronic Kidney Disease (CKD) Drugs Production Growth Rate (2014-2019)
- 3.4.2 North America Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Chronic Kidney Disease (CKD) Drugs Production
- 3.5.1 Europe Chronic Kidney Disease (CKD) Drugs Production Growth Rate (2014-2019)
- 3.5.2 Europe Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Chronic Kidney Disease (CKD) Drugs Production (2014-2019)
- 3.6.1 China Chronic Kidney Disease (CKD) Drugs Production Growth Rate (2014-2019)
- 3.6.2 China Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Chronic Kidney Disease (CKD) Drugs Production (2014-2019)
- 3.7.1 Japan Chronic Kidney Disease (CKD) Drugs Production Growth Rate (2014-2019)
- 3.7.2 Japan Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Chronic Kidney Disease (CKD) Drugs Consumption by Regions
- 4.1 Global Chronic Kidney Disease (CKD) Drugs Consumption by Regions
- 4.2 North America Chronic Kidney Disease (CKD) Drugs Consumption (2014-2019)
- 4.3 Europe Chronic Kidney Disease (CKD) Drugs Consumption (2014-2019)
- 4.4 China Chronic Kidney Disease (CKD) Drugs Consumption (2014-2019)
- 4.5 Japan Chronic Kidney Disease (CKD) Drugs Consumption (2014-2019)
5 Global Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price Trend by Type
- 5.1 Global Chronic Kidney Disease (CKD) Drugs Production Market Share by Type (2014-2019)
- 5.2 Global Chronic Kidney Disease (CKD) Drugs Revenue Market Share by Type (2014-2019)
- 5.3 Global Chronic Kidney Disease (CKD) Drugs Price by Type (2014-2019)
- 5.4 Global Chronic Kidney Disease (CKD) Drugs Production Growth by Type (2014-2019)
6 Global Chronic Kidney Disease (CKD) Drugs Market Analysis by Applications
- 6.1 Global Chronic Kidney Disease (CKD) Drugs Consumption Market Share by Application (2014-2019)
- 6.2 Global Chronic Kidney Disease (CKD) Drugs Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Chronic Kidney Disease (CKD) Drugs Business
- 7.1 Pfizer, Inc.
- 7.1.1 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.1.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.1.3 Pfizer, Inc. Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Amgen
- 7.2.1 Amgen Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.2.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.2.3 Amgen Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Roche
- 7.3.1 Roche Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.3.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.3.3 Roche Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 GlaxoSmithKline (GSK)
- 7.4.1 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.4.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.4.3 GlaxoSmithKline (GSK) Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Allergan
- 7.5.1 Allergan Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.5.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.5.3 Allergan Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 AbbVie
- 7.6.1 AbbVie Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.6.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.6.3 AbbVie Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Kissei Pharmaceutical Co., Ltd.
- 7.7.1 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Production Sites and Area Served
- 7.7.2 Chronic Kidney Disease (CKD) Drugs Product Introduction, Application and Specification
- 7.7.3 Kissei Pharmaceutical Co., Ltd. Chronic Kidney Disease (CKD) Drugs Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
8 Chronic Kidney Disease (CKD) Drugs Manufacturing Cost Analysis
- 8.1 Chronic Kidney Disease (CKD) Drugs Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Chronic Kidney Disease (CKD) Drugs
- 8.4 Chronic Kidney Disease (CKD) Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Chronic Kidney Disease (CKD) Drugs Distributors List
- 9.3 Chronic Kidney Disease (CKD) Drugs Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Chronic Kidney Disease (CKD) Drugs Market Forecast
- 11.1 Global Chronic Kidney Disease (CKD) Drugs Production, Revenue Forecast
- 11.1.1 Global Chronic Kidney Disease (CKD) Drugs Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Chronic Kidney Disease (CKD) Drugs Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Chronic Kidney Disease (CKD) Drugs Price and Trend Forecast (2019-2025)
- 11.2 Global Chronic Kidney Disease (CKD) Drugs Production Forecast by Regions (2019-2025)
- 11.2.1 North America Chronic Kidney Disease (CKD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Chronic Kidney Disease (CKD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.3 China Chronic Kidney Disease (CKD) Drugs Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Chronic Kidney Disease (CKD) Drugs Production, Revenue Forecast (2019-2025)
- 11.3 Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Chronic Kidney Disease (CKD) Drugs Consumption Forecast (2019-2025)
- 11.3.2 Europe Chronic Kidney Disease (CKD) Drugs Consumption Forecast (2019-2025)
- 11.3.3 China Chronic Kidney Disease (CKD) Drugs Consumption Forecast (2019-2025)
- 11.3.4 Japan Chronic Kidney Disease (CKD) Drugs Consumption Forecast (2019-2025)
- 11.4 Global Chronic Kidney Disease (CKD) Drugs Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Chronic Kidney Disease (CKD) Drugs Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Chronic Kidney Disease (CKD) Drugs . Industry analysis & Market Report on Chronic Kidney Disease (CKD) Drugs is a syndicated market report, published as Global Chronic Kidney Disease (CKD) Drugs Market Research Report 2019. It is complete Research Study and Industry Analysis of Chronic Kidney Disease (CKD) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
